Recruiting
Pulmonary Hypertension Observational Study
The purpose of this study is to establish the large PH cohort and biological database in China, aiming for precision medicine to optimize diagnosis and treatment choices.
ClinicalTrials.gov IDNCT05958901
PhaseNot Applicable
Enrollment10000
SponsorThe First Affiliated Hospital of Guangzhou Medical University
Age20 Years
SexALL
Conditions studied
Pulmonary Hypertension
About this study
The purpose of this study is to establish the large PH cohort and biological database in China, aiming for precision medicine to optimize diagnosis and treatment choices.
Interventions
- Other: pulmonary hypertension — The final outcome observed was a diagnosis of pulmonary hypertension.
Primary outcomes
- mean pulmonary arterial pressure (12 months)
Eligibility information
Inclusion Criteria:
* PH group: When the mean pulmonary artery pressure is greater than 25mmHg at rest or greater than 30mmHg during exercise.
* Signed informed consent obtained prior to participations with the ability to comply with protocol and be available for study visits over 5 years.
Exclusion Criteria:
* Acute exacerbation in the past 3 months Having other respiratory diseases with massive lung tissue destruction such as severe bronchiectasis and tuberculosis, etc.
* Serious uncontrolled diseases thoracic or abdominal surgery in the last 3 months.
* Eye surgery in the last three months.
* Retinal detachment myocardial infarction in the last 3 months.
* Admission to hospital for any cardiac condition in the last month.
* Heart rate over 120 beats per minute.
* Antibacterial chemotherapy for tuberculosis pregnant or breast feeding.
Study locations
- The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510000 China
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.